Fulgent Genetics (FLGT) Other Operating Expenses (2015 - 2026)

Fulgent Genetics has disclosed Other Operating Expenses across 12 years of filings, most recently posting $19.0 million for Q2 2026.

• In Q2 2026, Other Operating Expenses rose 33.29% year-over-year to $19.0 million; the TTM figure through Jun 2026 stood at $53.8 million (up 13.45% YoY), while the FY2025 annual figure was $49.9 million, up 12.87% from the prior year.
• Other Operating Expenses came in at $19.0 million for Q2 2026 at Fulgent Genetics, up from $11.7 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $134.1 million in Q4 2023 to a low of $6.9 million in Q1 2022.
• Average Other Operating Expenses over 5 years is $18.2 million, with a median of $11.5 million recorded in 2024.
• Year-over-year, Other Operating Expenses surged 1175.25% in 2023 and slumped 91.4% in 2024.
• Over 5 years, Other Operating Expenses stood at $10.5 million in 2022, then surged by 1175.25% to $134.1 million in 2023, then tumbled by 91.4% to $11.5 million in 2024, then declined by 0.23% to $11.5 million in 2025, then soared by 65.41% to $19.0 million in 2026.
• Per Business Quant data, the three most recent Other Operating Expenses figures were $19.0 million in Q2 2026, $11.7 million in Q1 2026, and $11.5 million in Q4 2025.